Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Medivir to present at the Stockholm Corporate Finance Life Science Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Stockholm Corporate Finance Life Science Day on March 9, 2023.CEO Jens Lindberg will present the company and its plan for the ongoing clinical study with fostroxacitabine bralpamide (fostrox) at 08.30 CET.  The presentation will be available after the meeting on Medivirs website; www.medivir.com.       For additional information, please contact

Asetek - Annual Report 2022

Aalborg, March 8, 2023. Asetek A/S has today published its Annual Report for 2022. The report is available online at www.asetek.com and at www.newsweb.no. For questions or further information, please contact: CFO Peter Dam Madsen, +45 2080 7200, email: investor.relations@asetek.com  About Asetek: Asetek (ASTK.OL), a global leader in mechatronic innovation, is a Danish garage-to-stock-exchange success story. Founded in 2000, Asetek established its innovative position as the leading OEM developer and producer of the all-in-one liquid cooler for all major PC & Enthusiast gaming

Ocean Yield - Successful placement of senior unsecured bonds

Ocean Yield AS has successfully completed a new bond issue of NOK 750 million, carrying a coupon of 3 months NIBOR + 3.95% p.a. with quarterly interest payments. The bond issue attracted strong interest and was well oversubscribed. The net proceeds from the bond issue will be applied towards refinancing of outstanding debt and general corporate purposes. Arctic Securities AS, Danske Bank, Nordea Bank Abp, filial i Norge and Skandinaviska Enskilda Banken AB (publ) acted as Joint Lead Managers in connection with the placement of the new bond issue. An application will be made for the bonds

Vår Energi ASA to hold fixed income investor meetings

Sandnes, Norway, 8 March 2023: Vår Energi ASA (OSE: VAR) today announce that a series of fixed income investor calls will be arranged. An inaugural Euro Benchmark sized RegS senior unsecured bond offering with a 6-year maturity issued off Vår Energi ASA’s EUR 3,000,000,000 EMTN Programme may follow, subject to market conditions. The net proceeds will be used for refinancing of existing indebtedness and general corporate purposes.  Contact Investor relations Ida Marie Fjellheim, Head of Investor Relations +47 90509291 ida.fjellheim@varenergi.no About Vår Energi Vår

Changes in Ferronordic’s management

Jonathan Tubb appointed Deputy Group CFO and joins the Group Executive Management Team.On 6 March 2023, Jonathan Tubb was appointed Deputy Group CFO in Ferronordic and member of the Executive Management Team. Jonathan has been CFO for Ferronordic’s Russia/CIS segment since 2017. He will continue his role in the CIS segment, which currently comprises of Kazakhstan. As Deputy CFO, he will also focus on Group operational finance issues. Jonathan has extensive experience in finance and audit. Before Ferronordic, Jonathan amongst other positions held partner roles in Deloitte and Ernst & Young.

Nixu – Correction: Nixu Corporation’s Annual Report 2022 is published

Nixu Corporation, Stock exchange release, March 8, 2023 at 3:45 PM EET  Nixu published today in English and Finnish the Annual Report 2022, which included the Financial Review in XHTML format in accordance with the European Single Electronic Format (ESEF) reporting requirements. The zip file did not open correctly due to which the entire release and its attachments are sent again: Nixu Corporation has today published its Annual Report for the year 2022. The Annual Report contains an Annual review, the Report by the Board of Directors, the Financial Statements 2022, Auditor’s Report,

Love Hate Inu Will Be The Next Meme Coin to Explode And It's in Presale From Today

Wednesday March 8th, 2023 – Meme coin meets Vote-to-Earn with Love Hate Inu  (LHINU) – it’s the next Shiba Inu and is set to go viral, helped by a uniquely valuable feature set. How do you feel about Donald Trump, Andrew Tate and Elon Musk? Do you love them or hate them? Everyone has an opinion and with Love Hate Inu’s secure voting system you can express yours. Leveraging the power of the blockchain, full transparency is guaranteed and there is no room for gaming the system as all voters must stake the $LHINU token in order to take part. Raises

Pihlajalinna Plc: Notice to Annual General Meeting

Pihlajalinna Plc                      Stock Exchange Release                      8 March 2023 3:30 p.m. Pihlajalinna Plc: Notice to Annual General Meeting Pihlajalinna Plc's Annual General Meeting will be held on Tuesday 4 April 2023 at 10:00 a.m. at Tampere Hall, Duetto 1 conference room, at Yliopistonkatu 55, 33100 Tampere, Finland. The reception of persons who have registered for the meeting and distribution of voting tickets will commence at the meeting venue at 9:00 a.m. The meeting is preceded by coffee service. Shareholders can also exercise their right to vote by voting in

Vestas secures 56 MW order in the USA

News release from Vestas-American Wind TechnologyPortland, 8 March 2023 Vestas has received a 56 MW order from RPM Access to power the Prescott wind project in Iowa, USA. The order consists of 13 V150-4.2 MW wind turbines delivered in 4.3 MW operating mode. “Working together with experienced regional partners like RPM Access is vital to achieving a clean energy transition in key markets like the Midwest. Vestas is excited to partner with RPM Access in Adams County, Iowa to enable and promote the growth of wind energy through Vestas’s industry-leading technology,” said Laura Beane,

SBB invests and signs a 30-year lease with the Municipality of Örebro

Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") has owned Mosjö School in Örebro since 2019. The project involves the rebuilding and extension of the school, which covers a total of 3,862 square meters. The lease is for 30 years and the tenant is the Municipality of Örebro. Mosjö School is expanding and needs larger premises. The school is a primary school and the project includes a two-storey extension containing classrooms and staff rooms and the reconstruction of, among other things, special rooms, dining room and kitchen. The extension is connected to the existing school with a

Saab publishes its 2022 Annual and Sustainability Report

Saab’s Annual and Sustainability Report for 2022 is as of today available on the Group’s website www.saab.com.The Annual and Sustainability Report 2022 is available in both Swedish and English, and describes Saab’s strategy to drive long-term sustainable value for all its stakeholders in a new market landscape. A key focus throughout the report is Saab’s contribution to safe and resilient societies and Saab’s progress within its sustainability commitments. “With the tragic war in Europe, the importance of Saab’s purpose to keep people and society safe has never been more evident. Saab

Skanska publishes Annual and Sustainability Report 2022: Strong performance in spotlight

Skanska has published its Annual and Sustainability Report for 2022, including a version in European Single Electronic Format (ESEF). The report, which is attached to this press release, can also be downloaded at group.skanska.com/investors . A printed copy of the report can be ordered on our website or via e-mail to investor.relations@skanska.se.To access the digital short version, please click here . The report, which includes financial statements and an overall summary of the year,

This year's first BioStock Investor Meeting – a perfect opportunity to get new ideas for your stock portfolio!

On March 16, we will arrange this year's first digital BioStock Investor Meeting. We start at 10am and round off around 1pm. 8 selected growth companies in the Life Science space will present their business cases to investors and potential partners. The full program is presented below.The event will be broadcasted on the BioStock website and on our YouTube channel. You can also access the event through our social media platforms.   Program 10.00 Abliva10.20 Xbrane Biopharma10.40 Xintela11.00 Chordate Medical11.20 Aqilion – Interview and expert insights11.40 QuiaPEG

Swiss-based Altium acquires major stake in PHI

Phase Holographic Imaging (PHI) announces that Altium S.A. recently acquired Formue Nord’s entire holdings in PHI of 2 416 679 shares and 1 491 362 TO 3 warrants and committed to exercise the obtained warrants.The acquired holdings correspond to 11,8 % of the total number of shares and votes in PHI. Altium had no holdings in PHI before this transaction. Altium CEO, Goran Dubravcic, notes: “PHI and Altium share the same vision that regenerative medicine will transform healthcare and cure presently incurable diseases. In this transformation of medicine, we see PHI’s non-invasive cell

Dicot contracts world leading medical expert within erectile dysfunction

Press release: Uppsala, Sweden, March 8, 2023. Dicot has entered into a consultancy agreement with medical doctor Harin Padma-Nathan, a world leading medical expert in male sexual dysfunctions. Dr Padma-Nathan was involved in the development of the drugs for erectile dysfunction currently on the market, e.g., as Lead Principal Investigator during the development of Viagra and Cialis. His Viagra paper in The New England Journal of Medicine is the most cited paper in the field of urology.Dicot is developing a novel potency drug aimed to become the first choice for treatment of erectile

Irreversibly captured by the human heart

Two years ago, Angela Kornberger brought her expertise as a cardiac surgeon and passion for saving lives to Getinge’s Medical and Clinical Affairs team. Today, she is part of creating tomorrow’s acute care therapy solutions, with the user perspective still top of mind. Angela Kornberger has had a fascination with the human heart and an eagerness to help people for as long as she can remember. “I always knew I wanted to become a doctor, ever since I was a child. In Medical School I tried different fields throughout the years, but I was irreversibly captured by the human heart.

CORRECTION: Herantis publishes 2H & FY 2022 Report

Correction to release sent on March 2[nd], 2023, at 8:00 a.m. EET: the release category has been updated by removal of “insider information” and the Key Figures table is now included in the release.  Nothing else differs from the previous release. Herantis Pharma Plc Company Release, March 7, 2023, at 19:40 EET/ 18:40 CET “We made good progress in 2022 achieving encouraging preclinical results and submitting clinical trial application (CTA) for HER-096. The compelling preclinical data supports the potential of HER-096 to be a disease-modifying therapy for Parkinson’s disease with a

Fifteen iconic female covers that celebrate female empowerment

A review of the year’s most inspiring magazine covers to kickstart the #EmbraceEquity conversation this International Women’s Day   With inclusion and belonging a key theme this International Women’s Day, digital subscription service Readly  has rounded up a list of the most inspirational women to have fronted magazine covers over the past year.   2022 was another eventful year for female change-makers as the impact of global events like the Russian invasion of Ukraine, protests in Iran, deepening inflation and climate change continue to impact the

Change in scope of Fazer’s planned confectionery factory investment – the company will investigate only the renewal of chocolate production

Fazer’s project to build a state-of-the-art confectionery factory in Finland has proceeded and is currently in the basic engineering phase. When the investment into the new factory was announced, the company communicated that in the first phase chocolate production, currently located in Vantaa, and then in a second phase, sugar confectionery production, currently located in Lappeenranta, would transfer to the new factory in Lahti. Significant changes in the operating environment, such as the rapid change in interest rates, changes in consumer behaviour and demand as well as the uncertainty

Strategic collaboration in Estonia progresses: Nightingale Health completes the analysis of 200,000 Estonian Biobank samples

Press release, 8 March 2023 at 1:30 p.m. (EET)  Nightingale Health Plc (“Nightingale Health”), a technology company promoting preventative health with its proprietary health risk detection platform, has analyzed and delivered to Estonian Biobank the analysis results from blood samples of 200,000 Estonian Biobank participants. Nightingale Health and Estonian Biobank announced in 2021 their long-term strategic collaboration constituting an initiative to empower the population of Estonia with modern tools of personalized medicine to realize early disease prevention. The participants of

Pihlajalinna’s change negotiations conclude – measures to strengthen profitable growth continue

Pihlajalinna Plc          Investor News          8 March 2023 at 13:15 p.m.  Pihlajalinna’s change negotiations conclude – measures to strengthen profitable growth continue  Pihlajalinna’s measures to strengthen profitable growth and financial position continue. As part of the measures, the company initiated change negotiations in January 2023. During the negotiations, the organisation’s structure and positions were evaluated. In addition, the partial downscaling, combining or closure of individual operating locations were assessed.  As a result of the negotiations, Pihlajalinna’s

Eklund Foundation for Odontological Research and Education allocates €250,000 for grants in 2023

€250,000 is the total sum allocated for research within dentistry by the Eklund Foundation in 2023. The application portal will be open during May for the eighth year running, welcoming applicants from all parts of the world in all fields of dentistry.Both experimental and clinical studies within all fields of dentistry are accepted, but the foundation will prioritise projects that can be related to periodontology, implantology, or cariology. Researchers may apply for funding for a project in its entirety or for part of a project. Even though thee application period runs during May, the

Director/PDMR Shareholding

8 March 2023 11:01 GMT Transactions by Persons Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 4 March 2023, certain Persons Discharging Managerial Responsibilities of the Company (PDMRs) were granted awards of the Company's ordinary shares of $0.25 each (Ordinary Shares) under the terms of the AstraZeneca Deferred Bonus Plan (AZDBP) and the AstraZeneca Performance Share Plan (AZPSP), as detailed in the table below. PDMR Position Ordinary Shares Ordinary Shares Award price per granted under the granted

There are no items matching the current filter
There are no more items matching the current filter
Back to top